ac22 - deciphering the role of cancer-associated myeloid cells in resistance to immunotherapy
Published 2 years ago • 94 plays • Length 9:59Download video MP4
Download video MP3
Similar videos
-
56:36
icrn webinar: targeting immunosuppressive myeloid cells in cholangiocarcinoma
-
3:26
the role of myeloid cells in tme
-
1:05:02
ac22 - session ii :: studying the neighborhood: lessons from the tumor microenvironment
-
26:50
ac22 - topaz-1 trial in biliary tract cancer
-
1:59
the role of tissue tension and myeloid cells in modulating tumor immunity
-
30:46
potential of immunotherapy for solid tumors including cancers of the bile duct - dr. lei zheng
-
10:53
ac22 - deep immune profiling of intrahepatic cholangiocarcinoma with codex multiplexed imaging
-
4:34
endometrial cancer uterus fda approved treatment - dr robert debernardo, md
-
12:46
2022 cri-enci-aacr international cancer immunotherapy conference (cicon22) highlights from day 2
-
56:28
webinar: “the perio-02 trial – enabling immunotherapy for intrahepatic cholangiocarcinoma”
-
11:05
ac22 - clonal origins of metastatic cholangiocarcinoma
-
59:00
icrn webinar: immune landscape of cholangiocarcinoma
-
1:07:28
understanding immunosuppressive myeloid cells and immunotherapy using proteome profiler™ arra
-
2:15
the role of immunotherapy in cholangiocarcinoma
-
3:19
the latest developments in immunotherapeutic targeting myeloid cells
-
1:25
targeting myeloid cells in the future of immuno-oncology
-
3:29
myeloid regulatory cells: novel players in cancer immunotherapy
-
1:08
the tumor-myeloid axis as a predictor of response to immunotherapy in nsclc
-
5:56
the emerging role of immunotherapy in cholangiocarcinoma